Other studies indicate that HMGB1 may be an important marker for assessing tumour staging and predicting prognosis in hepatocellular carcinoma, as HMGB1 levels in hepatocellular carcinoma were significantly higher than in chronic hepatitis, cirrhosis and healthy controls. This evidence concerns the gene HMGB1 and neoplasm.